Lung Deposition Using the Respimat
COPD
In vitro—in vivo correlation
drug delivery
olodaterol
simulation
throat model
tiotropium
Journal
COPD
ISSN: 1541-2563
Titre abrégé: COPD
Pays: England
ID NLM: 101211769
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
12
12
2020
medline:
25
11
2021
entrez:
11
12
2020
Statut:
ppublish
Résumé
Tiotropium and olodaterol are mainstay treatments for chronic obstructive pulmonary disease (COPD) and yield important clinical improvements, especially when used in fixed-dose combination. Whilst previous studies have shown consistent delivery of tiotropium to the lungs with the Respimat
Identifiants
pubmed: 33302718
doi: 10.1080/15412555.2020.1853091
doi:
Substances chimiques
Benzoxazines
0
Bronchodilator Agents
0
Tiotropium Bromide
XX112XZP0J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM